Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 7 029 1615 153 3646 229 9715 082 415--
Entreprise Value (EV)1 12 054 7439 609 0549 862 5228 339 9677 860 5797 415 529
P/E ratio 40,0x118x16,6x20,4x16,1x18,5x
Yield 3,98%5,44%4,52%5,57%5,57%5,57%
Capitalization / Revenue 3,35x1,57x1,95x1,50x1,51x1,55x
EV / Revenue 5,75x2,92x3,08x2,46x2,33x2,27x
EV / EBITDA 25,3x14,0x9,23x7,42x6,69x6,68x
Price to Book 1,36x1,09x1,20x0,98x0,98x0,99x
Nbr of stocks (in thousands) 1 554 7801 557 8491 563 3551 572 530--
Reference price (JPY) 4 5213 3083 9853 2323 2323 232
Announcement Date 05/14/201905/13/202005/11/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 2 097 2003 291 2003 197 8123 384 5713 371 4223 272 474
EBITDA1 477 415684 0571 068 9401 124 1591 175 1131 109 676
Operating profit (EBIT)1 205 000100 400509 269505 787540 557477 804
Operating Margin 9,77%3,05%15,9%14,9%16,0%14,6%
Pre-Tax Profit (EBT)1 94 896-60 754366 235415 744472 353454 706
Net income1 109 10044 200376 005251 743315 169269 196
Net margin 5,20%1,34%11,8%7,44%9,35%8,23%
EPS2 11328,0241158201174
Dividend per Share2 180180180180180180
Announcement Date 05/14/201905/13/202005/11/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3
Net sales1 836 720770 274949 600816 1991 799 800849 495
EBITDA ------
Operating profit (EBIT)1 143 112150 540248 600107 096357 150112 733
Operating Margin 17,1%19,5%26,2%13,1%19,8%13,3%
Pre-Tax Profit (EBT)1 109 796130 878222 978146 616269 500162 546
Net income1 92 352197 098200 40069 531186 50086 891
Net margin 11,0%25,6%21,1%8,52%10,4%10,2%
EPS2 59,612612826,911946,6
Dividend per Share ------
Announcement Date 02/04/202105/11/202107/30/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 5 025 5824 455 6903 632 5513 257 5512 778 1642 333 114
Net Cash position1 ------
Leverage (Debt / EBITDA) 10,5x6,51x3,40x2,90x2,36x2,10x
Free Cash Flow1 -2 507 219961 871617 401745 851827 957795 603
ROE (Net Profit / Equities) 3,00%0,90%7,60%6,22%7,33%6,34%
Shareholders' equity1 3 636 6674 911 1114 947 4344 046 0224 302 1144 246 591
ROA (Net Profit / Asset) 1,06%-0,46%2,85%3,14%3,83%3,52%
Assets1 10 334 963-9 710 01813 209 9378 016 5698 235 7607 638 208
Book Value Per Share2 3 3193 0323 3093 2903 2913 274
Cash Flow per Share2 397403599541570525
Capex1 77 677127 082111 206197 520198 620193 920
Capex / Sales 3,70%3,86%3,48%5,84%5,89%5,93%
Announcement Date 05/14/201905/13/202005/11/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 5 082 415 369 856
Capitalization (USD) 44 516 597 061
Net sales (JPY) 3 197 812 000 000
Net sales (USD) 27 952 074 692
Number of employees 47 099
Sales / Employee (JPY) 67 895 539
Sales / Employee (USD) 593 475
Free-Float 99,3%
Free-Float capitalization (JPY) 5 046 153 048 312
Free-Float capitalization (USD) 44 198 977 378
Avg. Exchange 20 sessions (JPY) 39 099 055 360
Avg. Exchange 20 sessions (USD) 341 764 843
Average Daily Capital Traded 0,8%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA